Uncovering the Truth: North Korea Tied to 2019 Ethereum Theft Valued at $55 Million

South Korean Authorities Identify North Korean Hackers in Ethereum Heist The Breakthrough in the Investigation In a significant development, South Korean authorities have officially identified North Korean hackers as the perpetrators of a major Ethereum heist in 2019. The stolen cryptocurrency, valued at 58 billion won (approximately $55.7 million) at the time, was traced back…

Read More

Unlocking the Potential: A Heartfelt Look at XRP’s Price Forecast for November 22nd – Aiming for a Target of $2

XRP’s Price Surges After SEC Chair’s Resignation The Ripple Effect of Gary Gensler’s Departure In a surprising turn of events, XRP’s price has skyrocketed over 24% in the last 24 hours following the announcement of SEC Chair Gary Gensler’s resignation. This news comes as a welcome relief to Ripple and its supporters, who have been…

Read More

Franklin Intermediate Investment Grade Credit SMA Q3 2024 Commentary: A Charming and Engaging Read

Franklin Intermediate Investment Grade Credit SMA Performance Data Average Annual Total Returns (USD %) 3 Mths Franklin Intermediate Investment Grade Credit SMA – Pure GROSS 4.07 4.93 9.84 0.85 1.97 2.37 3.76 Franklin Intermediate Investment Grade Credit SMA – NET 3.69 3.77 8.22 -0.64 0.48 1.18 2.69 Bloomberg US Intermediate Credit Index 4.58 5.55 11.46…

Read More

Clever, Personable, and Unconventional: XRP Gains Momentum with Whale Activity Pointing to 15% Breakthrough

XRP Whales Making Waves in the Cryptocurrency Market An Unconventional Surge XRP is gaining prominence in the cryptocurrency market, propelled by a substantial purchasing surge from major investors referred to as whales. These whales have been making big waves in the market, sending shockwaves throughout the industry. Within a single week, these whales have amassed…

Read More

Breaking News: Hemogenyx Pharmaceuticals PLC Receives IRB Approval for Phase I Clinical Trial!

Breaking News: Hemogenyx Pharmaceuticals PLC Receives IRB Approval for Phase I Clinical Trial! Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1) LONDON, UK / ACCESSWIRE / November 22, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), a biopharmaceutical company developing innovative therapies and treatments for blood diseases, is pleased to announce that…

Read More